Thrombotic Microangiopathy as a Cause of Chronic Kidney Transplant Dysfunction: Case Report Demonstrating Successful Treatment with Eculizumab

Transplantation Proceedings

Volumn 47, Issue 7, 2015, Pages 2258-2261

  Iqbal, Z ^a   Wood, K ^b   Carter, V ^c,d   Goodship, T H ^a,d   Brown, A L ^a   Sheerin, N S ^a,d  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ECULIZUMAB; MYCOPHENOLATE MOFETIL; PREDNISOLONE; TACROLIMUS; MONOCLONAL ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; CASE REPORT; CHRONIC ALLOGRAFT NEPHROPATHY; COMPLEMENT ACTIVATION; CONFERENCE PAPER; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIDDLE AGED; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; CHRONIC DISEASE; KIDNEY; PATHOLOGY; PRIMARY GRAFT DYSFUNCTION; RECURRENT DISEASE; THROMBOTIC MICROANGIOPATHIES;

ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; RECURRENCE; THROMBOTIC MICROANGIOPATHIES;

EID: 84940991737     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.08.004     Document Type: Conference Paper

References (9)

1. M. Noris, J. Caprioli, E. Bresin, C. Mossali, G. Pianetti, S. Gamba, and et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype Clin J Am Soc Nephrol 5 2010 1844 1859
2. E. Bresin, E. Daina, M. Noris, F. Castelletti, R. Stefanov, P. Hill, and et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background Clin J Am Soc Nephrol 1 2006 88 99
3. M. Noris, and G. Remuzzi Thrombotic microangiopathy after kidney transplantation Am J Transplant 10 2010 1517 1523
4. J.M. Saland, S.H. Emre, B.L. Shneider, C. Benchimol, S. Ames, J.S. Bromberg, and et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation Am J Transplant 6 2006 1948 1952
5. C.M. Legendre, C. Licht, P. Muus, L.A. Greenbaum, S. Babu, C. Bedrosian, and et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome N Engl J Med 368 2013 2169 2181
6. J. Zuber, M. le Quintrec, S. Krid, C. Bertoye, V. Gueutin, A. Lahoche, and et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation Am J Transplant 12 2012 3337 3354
7. V. Frémeaux-Bacchi, E. Miller, M. Liszewski, L. Strain, J. Blouin, A. Brown, and et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome Blood 112 2008 4948 4952
8. K.H. Olie, S. Florquin, J. Groothoff, R. Verlaak, L. Strain, T. Goodship, and et al. Atypical relapse of hemolytic uremic syndrome after transplantation Pediatr Nephrol 19 2004 1173 1176
9. K. Lhotta, A.R. Janecke, J. Scheiring, B. Petzlberger, T. Giner, V. Fally, and et al. A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure Clin J Am Soc Nephrol 4 2009 1356 1362